Clinical Trial Update: QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for QLC7401 monotherapy in primary hypercholesterolemia or mixed dyslipidemia, sponsored by Qilu Pharmaceutical, with status NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• QLC7401

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | Status: NOT_YET_RECRUITING